logo

For the Inventor, By the Inventor

New York, NY, United States of America

The Rockefeller University


USPTO Granted Patents = 712



Trademarks = 12

Forward Citations = 7,869

Loading Chart...
Loading Chart...

691 inventors (with patents filed for the assignee):

goldMedal Anthony Cerami (76 out of 167 patents)

silverMedal Vincent A Fischetti (57 out of 85 patents)

bronzeMedal Peter C Ulrich (36 out of 79 patents)

4.  Thomas Tuschl (32 out of 76 patents)

5.  Michel Nussenzweig (32 out of 32 patents)

6.  Jeffrey V Ravetch (26 out of 33 patents)

7.  Nam-Hai Chua (26 out of 41 patents)

8.  Jeffrey M Friedman (26 out of 38 patents)

9.  Brian T Chait (26 out of 32 patents)

10.  Pamela J Bjorkman (24 out of 32 patents)

11.  Paul Greengard (24 out of 29 patents)

12.  James E Darnell, Jr (24 out of 27 patents)

13.  Sohail Tavazoie (23 out of 26 patents)

14.  Ralph M Steinman (21 out of 24 patents)

15.  Ricardo Proenca (19 out of 21 patents)


Core Competencies:
Anti-HIV Vaccines
Neutralizing Antibodies
CRISPR-Cas Systems
Hybrid Multi-Photon Microscopy
Immunomodulation
Olfactory Dysfunction
Anti-Inflammatory Polypeptides
Bioactive Agents
Angiogenesis Disorders
Melanoma Treatment
Sequence Specific Antimicrobials
Chimeric Bacteriophages

712 patents:

1. 12459990 - Anti-HIV vaccine antibodies with reduced polyreactivity (2025-11-04),
2. 12441782 - Anti-HIV antibody 10-1074 variants (2025-10-14),
3. 12428472 - Human immunodeficiency virus neutralizing antibodies and methods of use thereof (2025-09-30),
4. 12384848 - Anti-inflammatory polypeptides (2025-08-12),
5. RE50507 - Compositions and methods for modulating neuronal excitability and motor behavior (2025-07-29),
6. 12364429 - Compositions and methods for a universal clinical test for olfactory dysfunction (2025-07-22),
7. 12338277 - Broadly neutralizing antibodies that target HIV ENV V3 N-glycans (2025-06-24),
8. 12295993 - Sequence specific antimicrobials (2025-05-13),
9. 12285466 - Sequence specific antimicrobials (2025-04-29),
10. 12280078 - Modified microorganisms expressing saga and related compositions for immunomodulation against infection and cancer immunotherapy (2025-04-21),
11. 12265030 - Hybrid multi-photon microscopy (2025-04-01),
12. 12251450 - Delivery, use and therapeutic applications of the CRISPR-Cas systems and compositions for HBV and viral diseases and disorders (2025-03-18),
13. 12246061 - Sequence specific antimicrobials (2025-03-11),
14. 12239698 - HIV vaccine immunogens (2025-03-04),
15. 12234278 - Combination of broadly neutralizing HIV antibodies and viral inducers (2025-02-25),
The Rockefeller University is a world-renowned center for research and graduate education in the biomedical sciences, chemistry, and physics. Founded in 1901, it was the first institution in the United States dedicated solely to biomedical research. The university's mission is to improve the understanding of life for the benefit of humanity. Its scientists have made numerous groundbreaking discoveries leading to major advances in biology and medicine.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
712 Patents

#22 in New York, NY

#44 in New York

#692 in US

#1,370 in the World

...
New York, NY, United States of America

The Rockefeller University

Forward Citations = 7,869

691 inventors:

goldMedal Anthony Cerami (76 out of 167 patents)

silverMedal Vincent A Fischetti (57 out of 85 patents)

bronzeMedal Peter C Ulrich (36 out of 79 patents)

4.  Thomas Tuschl (32 out of 76 patents)

5.  Michel Nussenzweig (32 out of 32 patents)

Please report any incorrect information to support@idiyas.com
Loading…